Publication | Closed Access

Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer

Cancer ImmunosurveillanceNon-small-cell Lung CancerMedicineImmunologyCancer GenomicsBronchial NeoplasmImmune Checkpoint InhibitorCancer TreatmentLung CancerImmunotherapyOncologyRadiation OncologyTumor Microenvironment